SUMMARY Avian coccidiosis, an intestinal disease caused by protozoan parasites of the genus Eimeria, occurs worldwide. It is considered to be one of the most economically important diseases of domestic poultry. For many years, prophylactic use of anticoccidial feed additives has been the primary means of controlling coccidiosis in the broiler industry and has played a major role in the growth of this industry, which now can produce about 7.6 billion chickens annually. However, development of anticoccidial resistance has threatened the economic stability of the broiler industry. Although there has been little effort by the pharmaceutical industry to develop new anticoccidials, the mounting problem of drug resistance of Eimeria species has prompted major research efforts to seek alternative means of control through increased knowledge of parasite biology, host response, and nutritional modulation. As a consequence, important advancements have been made, particularly in defining parasite antigens that have potential use in vaccines, defining the Eimeria genome, understanding the immunology of coccidial infections, and the practical applications of live vaccines. This review describes the progress in these areas, most of which has occurred within the past 10 to 15 years.
Segmented filamentous bacteria (SFB) are nonpathogenic bacteria that are commonly found attached to the intestinal walls of many animals. Until now, these bacteria have not been cultured in vitro. Recently, a 16s rRNA sequence analysis revealed that SFB isolated from mice represent a distinct subline within the Cfostridium subphylum of the gram-positive bacteria. Since SFB isolated from mice, rats, and chickens are known to be host specific, we investigated the phylogenetic relationships among SFB obtained from these three hosts.Total DNAs from the intestinal floras of chickens and rats were used as templates for PCR amplification of 16s rRNA genes. PCR products were cloned and screened by a dot blot hybridization procedure to identify homologous sequences that cross-reacted with mouse SFB-specific oligonucleotide probes. A phylogenetic analysis of these 16s ribosomal DNA sequences revealed that SFB isolated from these three hosts form a natural group, which is peripherally related to the genus Cfostridiurn sensu strict0 (group I Cfostridiurn). The SFB obtained from chickens, rats, and mice had closely related, albeit different, 16s rRNA gene sequences. The observed levels of 16s rRNA sequence divergence, ca. 1.5 to 3%, together with host specificity, suggest that SFB isolated from mice, rats, and chickens represent different species and that coevolution of the SFB and their hosts occurred. "Candidatus Arthromitus" is proposed as the provisional generic name for this group of organisms.The small intestines of many animals (e.g., mice, rats, pigs, and other mammals, as well as chickens, amphibians, and insects) are inhabited by segmented filamentous bacteria (SFB), which are also referred to as long segmented filamentous organisms (reviewed in reference 10). These bacteria cannot be cultured in vitro and do not have official taxonomic names. Until recently, SFB could be recognized only on the basis of their morphology and their ecological niches. In intestines, these gram-positive, endospore-forming organisms are attached via holdfasts to the epithelial walls. In rodents, colonization by SFB is restricted to the ileum (4). In birds, SFB are also found in the ceca (9). No pathologic effects of SFB have been found, even in immunodeficient animals. SFB found in different animal species are morphologically very similar. However, attempts to transfer bacteria from one host species to another have revealed that SFB found in mice, rats, and chickens exhibit host specificity (1, 13, 21). It is not known if SFB that inhabit different hosts are taxonomically closely related or whether they belong to different species.In a recent study, the 16s rRNA-encoding gene sequence of SFB obtained from mice was determined (19). This study was greatly facilitated by the use of a monoculture of these organisms in formerly germfree mice (12). A comparative 16s rRNA * Corresponding author. Mailing address: Central Animal Laboratory, University of Nijmegen, P.O. Box 9101, NL-6500 HB Nijmegen, 'The Netherlands. analysis revealed that th...
The incidence of necrotic enteritis (NE) due to Clostridium perfringens (CP) infection in commercial poultry has been increasing at an alarming rate. Although pre-exposure of chickens to coccidia infections is believed to be one of the major risk factors leading to NE, the underlying mechanisms of CP virulence remain undefined. The objectives of this study were to utilize an experimental model of NE produced by Eimeria maxima (EM) and CP coinfection to investigate the pathologic and immunologic parameters of the disease. Broilers coinfected with EM plus CP exhibited more severe gut pathology compared with animals given EM or CP alone. Additionally, EM/CP coinfection increased the numbers of intestinal CP bacteria compared with chickens exposed to an identical challenge of CP alone. Coinfection with EM and CP repressed nitric oxide synthase gene expression that was induced by EM alone, leading to lower plasma NO levels. Intestinal expression of a panel of cytokine and chemokine genes following EM/CP coinfection showed a mixed response depending on the transcript analyzed and the time following infection. In general, IFN-alpha, IFN-gamma, IL-1beta, IL-2, IL-12, IL-13, IL-17, and TGF-beta4 were repressed, whereas IL-8, IL-10, IL-15, and LITAF were increased during coinfection compared with challenge by EM or CP alone. These results are discussed in the context of EM and CP to act synergistically to create a more severe disease phenotype leading to an altered cytokine/chemokine response than that produced by infection with the individual pathogens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.